Millennium Management’s KALA BIO KALA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,721
Closed -$944K 6151
2024
Q4
$944K Sell
2,721
-94
-3% -$29.6K ﹤0.01% 4248
2024
Q3
$802K Sell
2,815
-31
-1% -$9.78K ﹤0.01% 4442
2024
Q2
$1.01M Buy
2,846
+178
+7% +$58.8K ﹤0.01% 4103
2024
Q1
$1.05M Buy
2,668
+15
+0.6% +$5.57K ﹤0.01% 4257
2023
Q4
$929K Sell
2,653
-34
-1% -$12K ﹤0.01% 4220
2023
Q3
$1.2M Buy
2,687
+110
+4% +$72.2K ﹤0.01% 4046
2023
Q2
$1.88M Sell
2,577
-292
-10% -$227K ﹤0.01% 3535
2023
Q1
$2.16M Buy
2,869
+1,355
+89% +$1.18M ﹤0.01% 3370
2022
Q4
$2.89M Buy
1,514
+1,291
+579% +$511K ﹤0.01% 3247
2022
Q3
$124K Sell
223
-6
-3% -$4.71K ﹤0.01% 5888
2022
Q2
$172K Buy
229
+209
+1,045% +$328K ﹤0.01% 5709
2022
Q1
$69K Sell
20
-5
-20% -$13.1K ﹤0.01% 6299
2021
Q4
$76K Sell
25
-36
-59% -$167K ﹤0.01% 6361
2021
Q3
$401K Buy
61
+50
+455% +$432K ﹤0.01% 5553
2021
Q2
$150K Sell
11
-270
-96% -$4.24M ﹤0.01% 6118
2021
Q1
$4.72M Sell
281
-50
-15% -$976K ﹤0.01% 2629
2020
Q4
$5.61M Buy
331
+215
+185% +$4.05M ﹤0.01% 2331
2020
Q3
$2.17K Sell
116
-27
-19% -$621K ﹤0.01% 2536
2020
Q2
$3.75M Sell
143
-194
-58% -$5.5M 0.01% 2025
2020
Q1
$7.4M Buy
337
+117
+53% +$1.87M 0.02% 1055
2019
Q4
$2.02M Sell
220
-4
-2% -$38.6K ﹤0.01% 2615
2019
Q3
$2.13M Sell
224
-4
-2% -$48.7K ﹤0.01% 2404
2019
Q2
$3.63M Sell
228
-94
-29% -$1.56M 0.01% 2025
2019
Q1
$6.66M Buy
322
+258
+403% +$4.58M 0.01% 1560
2018
Q4
$787K Sell
64
-93
-59% -$1.61M ﹤0.01% 2710
2018
Q3
$3.88M Sell
157
-83
-35% -$2.53M ﹤0.01% 1992
2018
Q2
$8.22M Sell
240
-160
-40% -$6.14M 0.01% 1463
2018
Q1
$15.8M Buy
400
+359
+876% +$13.6M 0.02% 1021
2017
Q4
$1.91M Buy
41
+16
+64% +$749K ﹤0.01% 2313
2017
Q3
$1.41M Buy
+25
New +$1.37M ﹤0.01% 2342

Other funds holding KALA

Millennium Management's KALA Position: Q1 2025 in Review

Millennium Management sold out of KALA BIO (KALA) in Q1 2025, closing a stake of 2,721 shares — an estimated $944K sold.

Millennium Management first reported a position in KALA in Q3 2017 and held it in 30 quarters. The position peaked at $15.8M in Q1 2018. 25 funds tracked by Wall St. Rank hold KALA as of Q1 2025.

  • Millennium Management reported no remaining KALA BIO position as of Q1 2025 after selling out during the quarter.
  • Millennium Management sold 2,721 KALA BIO shares in Q1 2025, an estimated $944K.
  • Millennium Management first reported a position in KALA BIO in Q3 2017 and held it in 30 quarters.
  • Millennium Management's KALA BIO position peaked at $15.8M in Q1 2018.
  • 25 funds tracked by Wall St. Rank held KALA BIO as of Q1 2025.

Based on Millennium Management's 13F filing for Q1 2025, filed 15 May 2025.